文献速递肺血管病与心包/心肌炎

血尿酸与肺高血压严重程度相关并预测临床结局

[Serum uric acid is associated with disease severity and an important predictor for clinical outcome in patients with pulmonary hypertension].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2017-01-01

该研究纳入173例经右心导管确诊的肺高血压患者及51例对照,随访中位24个月,发现血尿酸与肺血管阻力等严重程度指标相关,且高于425.5 μmol/L时预测预后敏感度50%、特异度72%,高尿酸组临床结局更差(P=0.027)。

要点

  • 血尿酸与肺高血压严重程度相关,重度组高于轻中度组和对照组。
  • 血尿酸>425.5 μmol/L预测不良结局的敏感度50%、特异度72%。
  • 高尿酸组较低尿酸组预后差(P=0.027)。

核心结论

  • 血尿酸水平与肺高血压严重程度明显相关,并对患者预后具有预测价值。

研究设计与样本

  • 单中心回顾性队列研究,纳入2010年1月至2015年12月住院经右心导管确诊的肺高血压患者173例(女112例,平均年龄38岁),另设51例无肺高血压对照。
  • 肺高血压诊断标准为右心导管测得平均肺动脉压≥25 mmHg。
  • 按Rp/Rs分为轻中度组(≤0.6,n=97)和重度组(>0.6,n=76),随访中位24个月(6~71个月),终点为心源性死亡或心肺移植。

主要发现

  • 肺高血压患者血尿酸与肺血管阻力(r=0.398)、体循环阻力(r=0.244)、右心房平均压(r=0.26)正相关,与心脏指数(r=-0.278)、混合静脉血氧饱和度(r=-0.322)负相关,P均<0.01。
  • 重度肺高血压组血尿酸高于轻中度组和对照组(P均<0.05)。
  • ROC曲线确定血尿酸425.5 μmol/L为预测预后的最佳临界值,敏感度50%、特异度72%,ROC曲线下面积0.617(95%CI 0.532~0.703)。
  • 高尿酸组(>425.5 μmol/L,n=66)较低尿酸组(≤425.5 μmol/L,n=107)预后差(P=0.027)。
  • 高尿酸组心脏指数和混合静脉血氧饱和度较低尿酸组低,NT-proBNP、右心房平均压、肺血管阻力和体循环阻力较高(P<0.01或0.05)。

关键数值与推荐

  • 肺高血压诊断标准:右心导管测得平均肺动脉压≥25 mmHg。
  • 严重程度分组:Rp/Rs≤0.6为轻中度,>0.6为重度。
  • 预后预测临界值:血尿酸425.5 μmol/L,敏感度50%、特异度72%。

临床怎么用

  • 在肺高血压患者中可检测血尿酸辅助评估疾病严重程度。
  • 血尿酸>425.5 μmol/L提示预后较差,可加强随访和干预。

局限性

  • 单中心回顾性研究,样本量有限(173例肺高血压患者)。
  • 血尿酸预测预后的敏感度仅50%,特异度72%,ROC曲线下面积0.617,预测效能有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: The growing body of literature showed a link between uric acid and pulmonary hypertension (PH), but the impact of hyperuremia on outcome of patients with PH has not been well defined. Therefore, the present study was performed to analyze the impact of uric acid on outcome of PH patients. Methods: One hundred seventy-three PH patients (112 females, mean age 38 years old), who were hospitalized in our department between January 2010 and December 2015, were included in our study, the PH diagnosis was made based on right heart catheterization examination result (mean pulmonary artery pressure≥25 mmHg(1 mmHg=0.133 kPa)). PH patients were divided into mild to moderate PH group (Rp/Rs≤0.6, n=97) and severe PH group (Rp/Rs>0.6, n=76). Fifty-one patients (33 females, mean age 45 years old) without PH based on right heart catheterization were included as control subjects. All participants were followed up for a median of 24 months(6-71 months). Clinical endpoints were defined as cardiogenic death or heart-and-lung transplantation. Results: Uric acid was positively correlated with pulmonary vascular resistance(r=0.398, P<0.01), systemic vascular resistance(r=0.244, P<0.01) and mean right atrial pressure (r=0.26, P<0.01), and was negatively correlated with cardiac index(r=-0.278, P<0.01)and mixed venous oxygen saturation (r=-0.322, P<0.01)in PH patients. Serum uric acid level was significantly higher in patients with severe PH than in patients with mild-to-moderate PH and the control subjects (both P<0.05). According to the receiver operating characteristic curve (ROC), 425.5 μmol/L was found to be the best cut-off value of serum uric acid level to predict the outcome of PH patients (sensitivity 50%, specificity 72%). During follow-up, patients with higher level of uric acid (>425.5 μmol/L) were linked with poorer clinical outcome compared to patients with uric acid <425.5 μmol/L(P=0.027). Conclusion: Our findings suggests that uric acid is associated with the severity of PH and higher uric acid level serves as an important predictor for poor clinical outcome of PH patients. 目的: 研究血尿酸水平对肺高血压严重程度及其预后的预测价值。 方法: 选取2010年1月至2015年12月在广东省人民医院住院行左、右心导管确诊为肺高血压的患者[静息状态下右心导管监测的肺动脉平均压≥25 mmHg(1 mmHg=0.133 kPa)]作为肺高血压组,共173例。另选取因其他疾病行左、右心导管并排除肺高血压的患者作为对照组,共51例。收集入选者的基线资料并进行随访,随访中位数时间为24个月(6~71个月),定义心力衰竭死亡、心脏移植为终点事件。检测所有入选者的血尿酸、N末端B型利钠肽原(NT-proBNP)、血肌酐、血红蛋白等实验室检查指标。将患者的血尿酸水平及其他实验室指标与右心导管结果进行相关性分析。比较对照组及不同严重程度的肺高血压患者的血尿酸水平。分析尿酸作为疾病严重程度预测因子的敏感度和特异度,并将该临界值作为随访分析的分组指标,分析两组预后的差异。 结果: (1)实验室指标与右心导管指标的相关性分析结果:肺高血压组患者血尿酸与肺血管阻力、体循环阻力和右心房平均压呈正相关(r分别为0.398、0.244和0.26,P均<0.01),与心脏指数和混合静脉血氧饱和度呈负相关(r分别为-0.278和-0.322,P均<0.01)。肺高血压组患者血尿酸水平高于对照组(P<0.05),且重度肺高血压组高于轻中度肺高压组(P<0.05)。经ROC曲线计算发现,当血尿酸高于425.5 μmol/L时预测肺高血压患者预后敏感度和特异度较好(敏感度50%,特异度72%, ROC曲线下面积=0.617, 95%CI 0.532~0.703)。(2)肺高压患者血尿酸水平与预后的关系:以425.5 μmol/L为分界点,将肺高血压组患者分为高尿酸组(血尿酸>425.5 μmol/L,n=66)及低尿酸组(血尿酸≤425.5 μmol/L, n=107)。结果发现,高尿酸组较低尿酸组患者预后差(P=0.027)。且高尿酸组患者心脏指数和混合静脉血氧饱和度均较低尿酸组低(P均<0.01),NT-proBNP、右心房平均压、肺血管阻力和体循环阻力则均较低尿酸高(P<0.01或0.05)。 结论: 血尿酸水平与肺高血压严重程度具有明显的相关性,对肺高血压患者预后具有预测价值。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Luo DL, Zhang CJ, Huang YG, et al. [Serum uric acid is associated with disease severity and an important predictor for clinical outcome in patients with pulmonary hypertension]. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 28648026. doi:10.3760/cma.j.issn.0253-3758.2017.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。